AI-Driven Tablet Manufacturing

Artificial Intelligence (AI) is rapidly optimising pharmaceutical formulation by enabling more precise, faster and cost-efficient drug formulation processes. Integration of AI technologies (such as machine learning and deep learning) with pharmaceutical formulation is commonly applied in drug formulation, including artificial neural networks (ANN) and logic systems. The integration of AI with formulation can predict drug behaviour, select excipients for optimisation, and design safer and more efficient dosage forms compared to traditional methods. AI-enabled instruments are currently employed across the pharmaceutical industry, in areas such as formulation optimisation, QC, and stability testing. Adoption of AI results in improved efficiency with data-driven decision-making and the ability to handle complex, multi-variable formulation problems; on the other hand, notable disadvantages such as high implementation costs, dependency on quality data, regulatory challenges, and the need for specialised technical expertise are observed. AI in pharmaceutical formulation has a wide scope in future, as it has the potential to revolutionise the production of medicine, accelerate novel drug delivery system design, and regulatory compliance processes. As AI continues to evolve, its role in pharmaceutical sciences is expected to expand significantly, bridging the gap between computational innovation and practical drug manufacturing, ultimately contributing to safer, more effective, and more accessible pharmaceutical products. This study comprises a detailed review of the application of artificial intelligence in pharmaceutical formulations, including the integration of existing technology with artificial intelligence.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24362543
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AI-Driven Tablet Manufacturing

Amit Kumar Jaiswal, Arpit Hadole, Rutika Gandhe, Sanjivani Khawashi
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

AI-Driven Tablet Manufacturing

Amit Kumar Jaiswal, Arpit Hadole, Rutika Gandhe, Sanjivani Khawashi
article en

Abstract

Artificial Intelligence (AI) is rapidly optimising pharmaceutical formulation by enabling more precise, faster and cost-efficient drug formulation processes. Integration of AI technologies (such as machine learning and deep learning) with pharmaceutical formulation is commonly applied in drug formulation, including artificial neural networks (ANN) and logic systems. The integration of AI with formulation can predict drug behaviour, select excipients for optimisation, and design safer and more efficient dosage forms compared to traditional methods. AI-enabled instruments are currently employed across the pharmaceutical industry, in areas such as formulation optimisation, QC, and stability testing. Adoption of AI results in improved efficiency with data-driven decision-making and the ability to handle complex, multi-variable formulation problems; on the other hand, notable disadvantages such as high implementation costs, dependency on quality data, regulatory challenges, and the need for specialised technical expertise are observed. AI in pharmaceutical formulation has a wide scope in future, as it has the potential to revolutionise the production of medicine, accelerate novel drug delivery system design, and regulatory compliance processes. As AI continues to evolve, its role in pharmaceutical sciences is expected to expand significantly, bridging the gap between computational innovation and practical drug manufacturing, ultimately contributing to safer, more effective, and more accessible pharmaceutical products. This study comprises a detailed review of the application of artificial intelligence in pharmaceutical formulations, including the integration of existing technology with artificial intelligence.

Zenodo (CERN European Organization for Nuclear Research)
Sant Gadge Baba Amravati University (IN)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon